Using AI to Match Patients with Clinical Trials for Proactive Treatment

We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology solutions that employ AI for data analysis, new treatments for various illnesses can be made safer, faster and more focused on specific conditions. It can be difficult to develop treatments for patients dealing with rare illnesses, as it is often difficult to find enough patients to conduct thorough clinical research. Further, because the condition is rare, there may be sparse literature on the illness and even fewer specialists to consult.